Case File
efta-efta00875043DOJ Data Set 9OtherFrom: Jeffrey Epstein <[email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00875043
Pages
3
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <[email protected]>
To: "Ens, Amanda" .<
Subject: Re: To Do: BRL step-up note - closing today
Date: Thu, 04 Apr 2013 18:03:02 +0000
yes
On Thu, Apr 4, 2013 at 1:54 PM, Ens, Amanda <
wrote:
Jeffrey, we should do another $lmm of the BRL step-up note for Southern Trust.
Thanks,
Amanda
Amanda Ens I Vice President I Global Investment Opportunities I
320 Park Ave, 14th Floor, New York, NY 10022
T: 212.622.7091 I F: 212.310.0108 I M: 646.643.3211
Original Message-----
From: Jeffrey Epstein [[email protected]]
Sent: Tuesday, March 12, 2013 12:43 PM Eastern Standard Time
To: Barrett, Paul S
Subject: Re: To Do: BRL step-up note - closing today
Ok
On Tuesday, March 12, 2013, Barrett, Paul S wrote:
NMLS ID: 853443
Hi Jeffrey
Left you a vm.
I do think we should put some money into this note. Being long brl Into the World Cup makes sense. Domestic
inflation should allow them to allow minor fx appreciation. And they will likely hike 150bps this year. We
don't have much Latam fit exposure. Our MXN is working well.
I think we should do 1mm in southern trust.
Paul
Sent with Good (
EFTA00875043
Original Message
From: Ens, Amanda
Sent: Tuesday, March 12, 2013 09:39 AM Eastern Standard Time
To: Jeffrey Epstein
Cc: Barrett, Paul S
Subject: To Do: BRL step-up note - closing today
Jeffrey,
With the Brazilian policy rate at 7.25% and rate hikes increasingly likely in an effort to stem inflation, we remain
structurally bullish on the Brazilian real due to the attractive carry.
Paul recommends you invest $2mm in this BRL currency note.
HSBC-issued SRI. Step-up Note
Tenor: 53 weeks
At expiry barrier protection: 15%
ATMS strike coupon: 5%
Step-Up strike: 3% OTMS
Step-up coupon: 23.5%
Max gain: 28.5%
•
If BRL performance is between -15% and 0%, you receive your principal back
•
If BRL performance is between 0% and 3%, +5% return
•
If BRL is 3% stronger at expiry, +28.5% return
•
If BRL performance is weaker than -15%, 1-for-1 loss from initial spot
More drivers of our constructive BRL view:
Brazil continues to have an inflationary problem, with y/y inflation above 6% and still rising. Even though many analysts
expect inflationary pressure to recede as the year progresses (J PM IB expects y/y inflation to fall to 5.6% by year end),
the stickiness of inflation has raised expectations that a tightening cycle is coming. Consequently, it was the comments
EFTA00875044
accompanying the decision to keep rates unchanged at 7.25% that mattered for markets last week. The statement duly
delivered. The reference to maintaining rates constant for a prolonged period of time was dropped and the committee
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal
privilege, and legal entity disclaimers, available at
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal
privilege, and legal entity disclaimers, available at
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00875045
Technical Artifacts (6)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Phone
212.310.0108Phone
212.622.7091Phone
646.643.3211Wire Ref
referenceRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.